Dilated Cardiomyopathy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

C-MRI Guidance of Implantable CRT-implantation in Non-ischemic Dilated Cardiomyopathy
Condition: Non-ischemic Dilated Cardiomyopathy Intervention: Other: ICD/CRT-D implantation Sponsors: Prof. Dr. med. Ingo Eitel; Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2020 Category: Research Source Type: clinical trials

MyoKardia Doses First Patient in Phase 2 Clinical Trial of Danicamtiv in Genetic Dilated Cardiomyopathy
BRISBANE, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK) today announced that the first patient has been dosed in the company’s Phase 2 clinical trial of danicamtiv (formerly MYK-491) in people... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 9, 2020 Category: Pharmaceuticals Source Type: clinical trials

Transendocardial Injection of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
Condition: Non-ischemic Dilated Cardiomyopathy Interventions: Biological: allogeneic human mesenchymal stem cells (hMSCs); Other: Placebo Sponsors: Joshua M Hare; United States Department of Defense; The University of Texas Health Science Center, Houston Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2020 Category: Research Source Type: clinical trials